Elevating vitamin C by oral delivery, intravenous infusion, or intraperitoneal injection could in principle help compensate for the downregulated SVCT2 expression and increase the uptake of vitamin C by breast cancer cells. Here, SLC23A2 is linked to breast carcinoma.